new drug development
Contact Info
Murali Ramachandra, PhD
Chief Executive Officer

Prior to assuming the CEO responsibility, Murali was serving as Chief Scientific Officer at Aurigene. Murali has extensive experience of over 25 years in running successful and innovative research and early development pipelines both at operational and strategic level. He received his PhD from University of Idaho, USA and was a Postdoctoral fellow at DuPont Experimental Station and University of Kansas Medical Centre, Kansas City, USA. He has worked on various aspects of drug discovery at the National Institute of Health, USA and Schering-Plough, USA before joining Aurigene. He has co-authored more than 70 publications in peer-reviewed journals and is an inventor of 24 granted US patents. Murali has been in Aurigene since February 2005.